Results for Beta Thalassemia

Share:
1 - 9 of 9
Gerd Blobel, MD, PhD
Gerd Blobel

Dr. Blobel investigates the fundamental mechanisms involving transcription factors, chromatin regulators, and higher order chromatin. He is gearing his basic science discoveries towards genetic and epigenetic treatment modalities. In addition, Dr. Blobel is interested in mechanism of epigenetic memory.

E-mail:
blobel [at] email.chop.edu
View Gerd Blobel's Profile

Comprehensive Center for the Cure of Sickle Cell Disease and Other Red Blood Cell Disorders

Sickle Cell Disease

Pioneering new approaches to diagnosis, care, and treatment for patients with red blood cell disorders with novel gene therapies and stem-cell-based treatments that aim to reduce symptoms and prolong life.

Rivella Laboratory

Rivella Laboratory

The Rivella Laboratory investigates erythropoiesis, iron metabolism and inflammation and develops new therapeutics for the cure of hemoglobinopathies.

Blobel Laboratory

Blobel Laboratory

The Blobel Lab investigates the fundamental mechanisms involving transcription factors, chromatin regulators, and higher order chromatin, gearing its basic science discoveries toward genetic and epigenetic treatment modalities.

Off Campus: Shall We Dance?

Published on
Jun 21, 2019
in Cornerstone Blog
Stefano Rivella, PhD
Come with us "Off Campus," and discover what our employees do for fun, recreation, and their communities. First up: Stefano Rivella, PhD.

From Sci-Fi to Real Life, Stefano Rivella, PhD, on the Verge of Discovery

Published on
Feb 18, 2019
in Cornerstone Blog
Stefano Rivella, PhD
Stefano Rivella, PhD, is developing a novel gene therapy that could help patients living with sickle cell disease and other debilitating red blood disorders.

In the News: Regulating Iron, Mother's Dedication, Knee Troubles

Published on
May 13, 2016
in Cornerstone Blog
CHOP Research In the News
This week’s stories span discovery (of a potential treatment for rare blood diseases), inspiration (from a mother who transformed grief over her daughter’s terminal disease into a foundation helping other families), and finding practical clinical insight (to distinguish a serious knee condition from a drug-treatable infection with similar symptoms).

Exploring Exosome-Mediated Stem Cell Engraftment for Hemoglobinopathies

Published on
May 8, 2019
in Cornerstone Blog
Meghana V. Kashyap, MD
A surgeon-scientist explores exosome-mediated stem cell engraftment as a means to lessen disease severity and enhance quality of life for children with hemoglobinopathies.

Enzyme Identified as Possible Novel Drug Target for Sickle Cell Disease, Thalassemia

Published on
Jul 19, 2018
in Press Releases
CHOP, Penn Researchers: CRISPR Screening Reveals Signaling Protein with Key Role in Regulating Hemoglobin in Red Blood Cells
1 - 9 of 9